Determining the supportive care needs, and distress, of Australian men with prostate cancer receiving hormone therapy: A cross-sectional study.

Helen Crowe; Nicholas Howard; Brindha Pillay; Peter Xiberras; Catherine Paterson; Charlotte Primeau

Determining the supportive care needs, and distress, of Australian men with prostate cancer receiving hormone therapy: A cross-sectional study.

Helen Crowe
, Nicholas Howard
, Brindha Pillay
, Peter Xiberras
, Catherine Paterson
, Charlotte Primeau

Nursing

Research output: Contribution to conference (non-published works) › Abstract

Abstract

The mainstay treatment for metastatic prostate cancer disease aims to reduce systemic testosterone levels, which can be achieved surgically or by chemical castration, known as androgen deprivation therapy (ADT).

Original language	English
Pages	17-17
Number of pages	1
Publication status	Published - 2018
Event	19th Asia-Pacific Prostate Cancer Conference - Brisbane Convention Centre, Brisbane, Australia Duration: 22 Aug 2018 → 25 Aug 2018

Conference

Conference	19th Asia-Pacific Prostate Cancer Conference
Abbreviated title	APPC 2018
Country/Territory	Australia
City	Brisbane
Period	22/08/18 → 25/08/18

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@conference{11a3d7edc6094b878cae27ec6f12fa90,

title = "Determining the supportive care needs, and distress, of Australian men with prostate cancer receiving hormone therapy: A cross-sectional study.",

abstract = "The mainstay treatment for metastatic prostate cancer disease aims to reduce systemic testosterone levels, which can be achieved surgically or by chemical castration, known as androgen deprivation therapy (ADT). ",

author = "Helen Crowe and Nicholas Howard and Brindha Pillay and Peter Xiberras and Catherine Paterson and Charlotte Primeau",

year = "2018",

language = "English",

pages = "17--17",

note = "19th Asia-Pacific Prostate Cancer Conference, APPC 2018 ; Conference date: 22-08-2018 Through 25-08-2018",

}

Determining the supportive care needs, and distress, of Australian men with prostate cancer receiving hormone therapy: A cross-sectional study. / Crowe, Helen; Howard, Nicholas; Pillay, Brindha et al.
2018. 17-17 Abstract from 19th Asia-Pacific Prostate Cancer Conference, Brisbane, Queensland, Australia.

Research output: Contribution to conference (non-published works) › Abstract

TY - CONF

T1 - Determining the supportive care needs, and distress, of Australian men with prostate cancer receiving hormone therapy: A cross-sectional study.

AU - Crowe, Helen

AU - Howard, Nicholas

AU - Pillay, Brindha

AU - Xiberras, Peter

AU - Paterson, Catherine

AU - Primeau, Charlotte

PY - 2018

Y1 - 2018

N2 - The mainstay treatment for metastatic prostate cancer disease aims to reduce systemic testosterone levels, which can be achieved surgically or by chemical castration, known as androgen deprivation therapy (ADT).

AB - The mainstay treatment for metastatic prostate cancer disease aims to reduce systemic testosterone levels, which can be achieved surgically or by chemical castration, known as androgen deprivation therapy (ADT).

M3 - Abstract

SP - 17

EP - 17

T2 - 19th Asia-Pacific Prostate Cancer Conference

Y2 - 22 August 2018 through 25 August 2018

ER -

Determining the supportive care needs, and distress, of Australian men with prostate cancer receiving hormone therapy: A cross-sectional study.

Abstract

Conference

UN SDGs

Fingerprint

Cite this